Detalhe da pesquisa
1.
Darolutamide does not interfere with OATP-mediated uptake of docetaxel.
Int J Cancer
; 155(2): 314-323, 2024 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38491867
2.
Defining the challenges and opportunities for using patient-derived models in prostate cancer research.
Prostate
; 84(7): 623-635, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38450798
3.
Capivasertib combines with docetaxel to enhance anti-tumour activity through inhibition of AKT-mediated survival mechanisms in prostate cancer.
Br J Cancer
; 130(8): 1377-1387, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38396173
4.
Toll-Like Receptor 3 Overexpression Induces Invasion of Prostate Cancer Cells, whereas Its Activation Triggers Apoptosis.
Am J Pathol
; 192(9): 1321-1335, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35750257
5.
Abiraterone switches castration-resistant prostate cancer dependency from adrenal androgens towards androgen receptor variants and glucocorticoid receptor signalling.
Prostate
; 82(5): 505-516, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35037287
6.
In vitro dose effect relationships of actinium-225- and lutetium-177-labeled PSMA-I&T.
Eur J Nucl Med Mol Imaging
; 49(11): 3627-3638, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35556158
7.
Preclinical Assessment of the Combination of PSMA-Targeting Radionuclide Therapy with PARP Inhibitors for Prostate Cancer Treatment.
Int J Mol Sci
; 23(14)2022 Jul 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35887398
8.
Extensive preclinical evaluation of lutetium-177-labeled PSMA-specific tracers for prostate cancer radionuclide therapy.
Eur J Nucl Med Mol Imaging
; 48(5): 1339-1350, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33094433
9.
Androgen receptor signalling impairs docetaxel efficacy in castration-resistant prostate cancer.
Br J Cancer
; 123(12): 1715-1719, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32989230
10.
NanoBiT System and Hydrofurimazine for Optimized Detection of Viral Infection in Mice-A Novel in Vivo Imaging Platform.
Int J Mol Sci
; 21(16)2020 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32824188
11.
Construction of a chimeric antigen receptor bearing a nanobody against prostate a specific membrane antigen in prostate cancer.
J Cell Biochem
; 120(6): 10787-10795, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30672018
12.
A bypass mechanism of abiraterone-resistant prostate cancer: Accumulating CYP17A1 substrates activate androgen receptor signaling.
Prostate
; 79(9): 937-948, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31017696
13.
Ex vivo treatment of prostate tumor tissue recapitulates in vivo therapy response.
Prostate
; 79(4): 390-402, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30520109
14.
Tumor heterogeneity, aggressiveness, and immune cell composition in a novel syngeneic PSA-targeted Pten knockout mouse prostate cancer (MuCaP) model.
Prostate
; 78(13): 1013-1023, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30133757
15.
Movember GAP1 PDX project: An international collection of serially transplantable prostate cancer patient-derived xenograft (PDX) models.
Prostate
; 78(16): 1262-1282, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30073676
16.
Correction to: In vitro dose effect relationships of actinium225 and lutetium177labeled PSMAI&T.
Eur J Nucl Med Mol Imaging
; 49(11): 3956-3957, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35614268
17.
Loss of SLCO1B3 drives taxane resistance in prostate cancer.
Br J Cancer
; 115(6): 674-81, 2016 09 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27537383
18.
Prostate cancer androgen biosynthesis relies solely on CYP17A1 downstream metabolites.
J Steroid Biochem Mol Biol
; 236: 106446, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38104728
19.
Intratumoral conversion of adrenal androgen precursors drives androgen receptor-activated cell growth in prostate cancer more potently than de novo steroidogenesis.
Prostate
; 73(15): 1636-50, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23996639
20.
Awe and anxiety for cancer cells: connecting scientists and patients in a holistic approach of metastasis research.
Res Involv Engagem
; 9(1): 85, 2023 Sep 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37752584